Results and comparison with patients matched from IPI database
| . | Present study . | IPI database . | P . |
|---|---|---|---|
| No. | 62 | 927 | |
| Distribution of prognostic factors, % | |||
| Stage III-IV | 92 | 94 | .40 |
| Elevated LDH | 95 | 95 | .99 |
| PS 2 to 4 | 55 | 43 | .09 |
| Age older than 60 y | 24 | 37 | .06 |
| More than 1 extranodal site | 48 | 44 | .51 |
| CR rate, % (95% CI) | 48 (35, 64) | 52 (49, 55) | .60 |
| FFS | |||
| Median, y | 1.9 | 1.0 | .71 |
| 1 year, % (95% CI) | 55 (43, 67) | 50 (47, 53) | |
| 2 year, % (95% CI) | 50 (38, 62) | 39 (36, 42) | |
| Overall survival | |||
| Median, y | 2.7 | 1.9 | .62 |
| 1 year, % (95% CI) | 74 (63, 85) | 64 (61, 67) | |
| 2 year, % (95% CI) | 58 (46, 70) | 49 (46, 52) |
| . | Present study . | IPI database . | P . |
|---|---|---|---|
| No. | 62 | 927 | |
| Distribution of prognostic factors, % | |||
| Stage III-IV | 92 | 94 | .40 |
| Elevated LDH | 95 | 95 | .99 |
| PS 2 to 4 | 55 | 43 | .09 |
| Age older than 60 y | 24 | 37 | .06 |
| More than 1 extranodal site | 48 | 44 | .51 |
| CR rate, % (95% CI) | 48 (35, 64) | 52 (49, 55) | .60 |
| FFS | |||
| Median, y | 1.9 | 1.0 | .71 |
| 1 year, % (95% CI) | 55 (43, 67) | 50 (47, 53) | |
| 2 year, % (95% CI) | 50 (38, 62) | 39 (36, 42) | |
| Overall survival | |||
| Median, y | 2.7 | 1.9 | .62 |
| 1 year, % (95% CI) | 74 (63, 85) | 64 (61, 67) | |
| 2 year, % (95% CI) | 58 (46, 70) | 49 (46, 52) |